Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q2 FY26 results · Jul–Sep 2025
Max Healthcare Institute reported revenue from operations of ₹2,135.47 crore (up 25.1% from Q2 FY25) and net profit of ₹491.30 crore (up 74.3% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,135.47 | 1,707.46 | +25.1% | 2,027.57 | +5.3% |
| Other income | 32.90 | 40.84 | −19.4% | 36.51 | −9.9% |
| Total income | 2,168.37 | 1,748.30 | +24.0% | 2,064.08 | +5.1% |
| Profit before tax | 446.03 | 373.69 | +19.4% | 400.43 | +11.4% |
| Net profit for the period | 491.30 | 281.81 | +74.3% | 307.97 | +59.5% |
| EPS, basic (₹) | 5.05 | 2.90 | +74.1% | 3.17 | +59.3% |
| Net margin (%) | 23.0 | 16.5 | 15.2 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 736.62 | 686.11 | +7.4% | 694.02 | +6.1% |
| Other income | 47.43 | 133.51 | −64.5% | 79.85 | −40.6% |
| Total income | 784.05 | 819.62 | −4.3% | 773.87 | +1.3% |
| Profit before tax | 215.66 | 318.15 | −32.2% | 222.88 | −3.2% |
| Net profit for the period | 160.42 | 231.30 | −30.6% | 166.03 | −3.4% |
| EPS, basic (₹) | 1.65 | 2.38 | −30.7% | 1.71 | −3.5% |
| Net margin (%) | 21.8 | 33.7 | 23.9 |
Consolidated
- Filed with BSE
- 14 Nov 2025, 21:04 IST
- Board meeting
- 14 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Nov 2025, 21:04 IST
- Board meeting
- 14 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE